Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor—Afatinib: In vitro and in vivo evaluation

This publication has 46 references indexed in Scilit:

• Preparation, Characterization, and In Vitro Evaluation of Lipidoid–Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol
  2019
• Biodegradable Micelles for NIR/GSH-Triggered Chemophototherapy of Cancer
  Nanomaterials, 2019
• Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer
  Biomaterials, 2017
• EGFR-targeted therapies in the post-genomic era
  Cancer and Metastasis Reviews, 2017
• Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations
  JAMA Oncology, 2017
• Lung Cancer Statistics
  2015
• Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy
  The Journal of Membrane Biology, 2014
• Antibody Conjugated PLGA Nanoparticles for Targeted Delivery of Paclitaxel Palmitate: Efficacy and Biofate in a Lung Cancer Mouse Model
  Small, 2013
• Saccharide Modified Pharmaceutical Nanocarriers for Targeted Drug and Gene Delivery
  Current Pharmaceutical Design, 2009
• PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
  Biomaterials, 2009